The first Sutro Biopharma trade was made in Q4 2019.
Since then Jim Simons bought shares fourteen more times and sold shares on eight occasions. The investor sold all their shares in Q4 2025 and doesn't own any shares in Sutro Biopharma anymore.
Avg closing price
Price range
Sold -142k shares
Q4 2025
Avg closing price
$9.49
Price range
$7.30
-
$12.00
Increased shares by 56.0% (+51.2k shares)
Q3 2025
Avg closing price
$8.51
Price range
$6.80
-
$10.60
Increased shares by 5.1% (+4.42k shares)
Q2 2025
Avg closing price
$8.18
Price range
$5.25
-
$13.00
Sold 14.4% shares (-14.6k shares)
Q1 2025
Avg closing price
$15.75
Price range
$6.51
-
$21.20
Increased shares by 22.6% (+18.7k shares)
Q4 2024
Avg closing price
$30.53
Price range
$18.20
-
$44.00
Increased shares by 15.1% (+10.9k shares)
Q3 2024
Avg closing price
$39.20
Price range
$28.80
-
$50.10
Increased shares by 48.1% (+23.4k shares)
Q2 2024
Avg closing price
$39.54
Price range
$29.20
-
$53.30
Sold 25.9% shares (-17k shares)
Q1 2024
Avg closing price
$44.18
Price range
$32.70
-
$56.50
Increased shares by 116.5% (+35.3k shares)
Q4 2023
Avg closing price
$31.73
Price range
$20.70
-
$45.40
Increased shares by 12.4% (+3.34k shares)
Q3 2023
Avg closing price
$43.57
Price range
$32.90
-
$49.00
Increased shares by 108.3% (+14k shares)
Q2 2023
Avg closing price
$49.78
Price range
$42.50
-
$58.80
Increased shares by 332.7% (+9.95k shares)
Q1 2023